Business Context and Reporting Period
This Form 8-K filing by Exponent, Inc. (EXPO) is dated April 6, 2026. The report details significant changes to the company's executive leadership and board of directors, effective May 1, 2026, and June 4, 2026, respectively.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel appointments and compensation arrangements rather than financial performance metrics.
Material Changes
- Executive Appointments: John D. Pye, Ph.D., was appointed President, and Eric Anderson was appointed Chief Financial Officer (CFO), both effective May 1, 2026.
- Role Transition: Richard L. Schlenker will cease his role as CFO on May 1, 2026, but will continue as Executive Vice President.
- Board Changes: Paul R. Johnston, Ph.D., will retire from the Board effective June 4, 2026. Karen Richardson will succeed him as Chairman of the Board.
Compensation and Management Commentary
The filing outlines the following compensatory arrangements for the new appointees:
- John D. Pye (President): Base salary of $650,000 and a grant of 21,000 stock options vesting annually over four years.
- Eric Anderson (CFO): Base salary of $525,000 and a grant of 12,600 stock options vesting annually over four years.
Management confirmed there are no undisclosed arrangements, family relationships with directors, or material interests in transactions requiring disclosure under Regulation S-K.
Investor Verification Checklist
- Verify the effective dates of the leadership transitions (May 1, 2026, for executives; June 4, 2026, for the Board).
- Confirm the vesting schedules and terms of the stock option grants for Dr. Pye and Mr. Anderson.
- Review the upcoming Annual Meeting of Stockholders on June 4, 2026, for the formal ratification of the Board changes.
- Monitor future filings for the first financial results under the new CFO leadership.